Navigation Links
SpeechEasy Seeks Proposals For Future Research Studies
Date:7/25/2009

In summary, the RFP solicits interested qualified institutions and/or individuals to conduct an efficacy or basic science research study regarding the use of SpeechEasy, or its associated technology. Priority is being given to proposals which address basic research on responses to perturbed auditory feedback in children between the ages of 8 and 18, including but not limited to speech fluency and its underlying acoustic and/or kinematic features. These studies are being created and supported in an effort to provide the company, the professional community and the public with information regarding the safety and long-term effectiveness of the SpeechEasy product and its technology.

Greenville, NC (PRWEB) July 25, 2009 -- Janus Development Group (Janus), the providers of SpeechEasy, the nation's leading provider of portable speech fluency devices, has issued a Request For Proposals (RFP) for new research studies.

In summary, the RFP solicits interested qualified institutions and/or individuals to conduct an efficacy or basic science research study regarding the use of SpeechEasy, or its associated technology. Priority is being given to proposals which address basic research on responses to perturbed auditory feedback in children between the ages of 8 and 18, including but not limited to speech fluency and its underlying acoustic and/or kinematic features. These studies are being created and supported in an effort to provide the company, the professional community and the public with information regarding the safety and long-term effectiveness of the SpeechEasy product and its technology.

In November 2007, Janus assembled an independent research review panel to assist with the development of RFPs, the evaluation of the submitted proposals, and the selection of final grant recipients. The first RFP was created and publicized in July 2008, with Dr. Ken Logan from the University of Florida selected as the award recipient. Dr. Logan is currently initiating his research, entitled the "Effect of Concurrent Behavioral Fluency Therapy Upon Stuttering Treatment Outcomes in Speakers who Use the SpeechEasy Device."

"We believe that this research is critically needed, so that both clients and Speech-Language Pathologists can be provided with the most accurate and relevant information possible regarding our device," said Alan Newton, president of Janus. "We highly encourage any researchers with a background or experience in the field of fluency and fluency disorders to apply for this grant."

The complete RFP can be viewed online at http://www.speecheasy.com/rfp/RFP2009.pdf

About SpeechEasy
SpeechEasy is a portable, fluency-enhancing device that helps a high percentage of people who stutter speak more fluently with less effort. In the US alone, over 7,000 people who stutter have been fitted with a SpeechEasy device since it was first made available to the public in June 2001. Similar to a hearing aid, SpeechEasy is worn in or around the ear. But rather than amplify sound, it alters the way the user hears his or her own voice - changing the pitch and delaying it slightly to trick the brain into hearing a second voice speaking in unison. Such "choral" speech can alleviate stuttering in varying degrees, depending on the individual. SpeechEasy was developed by a team of communication disorder researchers at East Carolina University, and is marketed exclusively by Janus Development Group. SpeechEasy devices are available via a network of state licensed, ASHA (American Speech Language Hearing Association)-certified speech language pathologists. More information about SpeechEasy is available at www.speecheasy.com.

For more information regarding SpeechEasy, its independent research review panel, or the associated RFP, contact Alan Newton, President, at 1-866-551-9042.

# # #

Read the full story at http://www.prweb.com/releases/2009/07/prweb2675664.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. It Isnt Just Vanity! Local MedSpa Seeks to Correct and Educate.
2. Courage Center Seeks Applications for 2009 Judd Jacobson Memorial Award
3. URAC Seeks Public Input on New Uniform External Review Standards for Health Plan and Health Utilization Management Organizations
4. Critical Access Hospital Consolidator Seeks Cost-Management Solutions with Broadlane
5. Oakland Port Commission Seeks Resolution to Allow Local Officials Real Power to Clean Up Diesel Truck Pollution; Improve Security, Safety
6. A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video
7. Wounded Warrior Project (WWP) Seeks to Provide Mind, Body and Spirit Healing for Combat Stress
8. The Pennsylvania Breast Cancer Coalition Seeks Breast Cancer Survivors Throughout Pennsylvania
9. Insurance Department Seeks Comment On Community Health Reinvestment Activities
10. Lupus Foundation of America Seeks Proposals for Research Studies on Childhood Lupus and Stem Cell Transplantation
11. Virginia Hospital Center Seeks to Reduce Operating Costs and Improve Supply Chain with Broadlane
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , ... March 28, 2017 , ... ... is the first technology to directly address the resolution to globally reduce the ... is a patented compound of FDA and TTB approved ingredients that when infused ...
(Date:3/28/2017)... ... 29, 2017 , ... The Thyroid Secret is a specialized ... The program was recently launched on March 1, and Dr. Wentz discussed varied ... , Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... dedicated to advancing the science and clinical practice of radiosurgery, announced today ... Registry, a multi-institutional, observational registry established to standardize data collection from patients ...
(Date:3/28/2017)... DC (PRWEB) , ... March 28, 2017 , ... WHO: ... Dr. Toni Bark , WHAT: , Medical doctors and PhD scientists will speak to ... written to President Trump in support of an independent vaccine safety commission. , ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Paul Yost, will begin serving as new board chair for Orange County health ... will serve the remainder of soon-to-be former chair Mark Refowitz’s term, which runs ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  Rosen Law Firm, a ... a class action lawsuit on behalf of purchasers of ... ) pursuant and/or traceable to Kitov,s initial public offering ... on the open market from November 20, 2015 through ... The lawsuit seeks to recover damages for Kitov investors ...
(Date:3/28/2017)... , March 29, 2017 ... Siteless CRO platform, announced today study results ... Managed Care Pharmacy, #AMCP2017, Managed Care and Specialty Pharmacy ... . Data in both posters demonstrated that pharmacist-led ... and protocol adherence. These factors are crucial to generating ...
(Date:3/28/2017)... , March 28, 2017 Emosis SAS, ... new business entity, Emosis Ltd, headquartered in Tel Aviv ... novel assays complementing the mother company existing technology platform and test ... sales development of Emosis kits. ... This strategic move starts building Emosis international footprint. Emosis ...
Breaking Medicine Technology: